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ABSTRACT 
Objectives: To investigate maternal serum catalase, myeloperoxidase and ferroxidase levels in pregnant women with 
Hyperemesis Gravidarum and to compare the results with healthy pregnancies.
Material and methods: In this study, 60 female patients admitted to the Health Sciences University, Gazi Yaşargil Training 
and Research Hospital, Gynecology and Obstetrics Department were evaluated. The patients were divided into two groups: 
Group 1 included 30 pregnant women with hyperemesis gravidarum; Group 2 included 30 healthy pregnant women. 
Pregnancies over 14 weeks were excluded from the study. 
Results: The laboratory and laboratory characteristics of both groups are shown in Table 1. No significant differences were 
found between the groups in terms of the maternal age, gestational age, gravidity, parity, fasting glucose level, and BMI. 
The maternal blood CAT levels were significantly higher in the HG group (219.6 ± 111.3 kU/L) when compared to the control 
group (71.5 ± 52.5 kU/L) (p < 0.001). The maternal blood MPO levels were lower in the control group (121.5 ± 36.3 U/L) 
than in the study group (90.9 ± 56.4 U/L) (p = 0.016). However, the ferroxidase levels were similar between the two 
groups. The independent variables BMI, age, parity, gravidity and gestational week effects were adjusted according to the 
logistic regression method with groups. Significant differences were observed between the two groups in the levels of 
CAT (0.001), MPO (0.005) values. 
Conclusions: This study suggests that antioxidants in response to oxidative stress gave different reactions with different 
mechanisms; Also, we believe that insufficient food intake suppresses the immune system and this has an important role 
on antioxidants.
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INTRODUCTION
Nausea and vomiting can be seen in 80% of pregnant 
women in the first months of pregnancy [1]. Nausea and 
vomiting is a severe form of hyperemesis gravidarum (HG) 
and occurs in 0.3–3% of all pregnancies. When severe nausea 
and vomiting occur more often than three times a day in 
a patient with ketonuria and a weight loss of more than 5%, 
the patient is diagnosed with HG [2–4]. 
The HG etiology has not yet been fully elucidated [5]; 
however, many oxidative stressors are known to play roles 
in HG [6], including an imbalance between the oxidants and 
antioxidants. Oxidative stress (OS) refers to an imbalance 
between the production of reactive oxygen species and the 
antioxidant defence system that buffers oxidative damage, 
resulting in cellular, molecular damage. It has been reported 
652
Ginekologia Polska 2019, vol. 90, no. 11
www. journals.viamedica.pl/ginekologia_polska
that antioxidant activity is significantly higher in women 
with healthy pregnancies when compared to women who 
are not pregnant [7]. 
The antioxidant defence system includes ferroxidase, 
which converts toxic ferrous iron to less toxic ferric iron, 
thereby reducing oxidative damage to the cellular and mo-
lecular [8, 9]. Catalase (CAT), an intracellular antioxidant, 
increases to compensate for redox reactions in OS [10]. 
Myeloperoxidase is another intracellular enzyme that acts 
as an antioxidant in neutrophils. A decrease in antioxidant 
activity or an increase in free radicals will lead to OS [11, 12]. 
In this study, the ferroxidase, CAT, and MPO serum levels 
in the blood of HG patients were determined, and the results 
were compared with those of healthy pregnant women.
MATERIAL AND METHODS
This prospective study included a total of 60 pregnant 
women admitted to the Gynecology and Obstetrics De-
partment of the Health Science University Diyarbakır Gazi 
Yaşargil Training and Research Hospital in Diyarbakir, Turkey, 
between December 2017 and December 2018. The patients 
were divided into two groups: group 1 included 30 pregnant 
women with HG and group 2 included 30 healthy pregnant 
women. This research was conducted following the princi-
ples of the Helsinki Declaration, and informed consent was 
obtained from all of the participants. 
The HG diagnosis inclusion criteria were as follows: se-
vere and persistent nausea and vomiting more than three 
times per day during pregnancy, ketonuria, and greater 
than 5% weight loss [5]. Those patients with comorbid 
diseases (such as trophoblastic diseases, gestational dia-
betes, preeclampsia, thyroid diseases, infectious diseases, 
inflammatory diseases, renal diseases, hepatic diseases, and 
psychiatric disorders), smoking and alcohol habits, chronic 
medication use, and pregnancies over 14 weeks were ex-
cluded from the study. The following patient characteristics 
were recorded: maternal age, parity, gravidity, body mass 
index (BMI), and the gestational week at sampling. 
Venous blood samples were centrifuged at 4,000 rpm 
for 10 minutes, sera were separated and stored at –80°C 
until the MPO, ferroxidase, and CAT levels were analysed.
 Activity of CAT was evaluated by Goth’s method [13]. 
Sample (0.2 mL) was incubated in 1.0 mL substrate (65 µmol 
per in 60 hydrogen peroxide (H2O2) mmol/L sodium-potas-
sium phosphate buffer, pH 7.4) at 37°C for 60 seconds. The 
enzymatic activity was stopped with 1.0 mL of 32.4 mM 
ammonium molybdate, and the yellow complex of molyb-
date and H2O2 was measured at 405 nm. CAT activity was 
presented kU/L.
Activity of MPO was evaluated by a modification of 
the o-dianisidine method [14], a kinetic measurement with 
a yellowish orange product ratio; MPO from the oxidation 
of O-dianiside in the presence of hydrogen peroxide was 
measured at 460 nm. MPO activity was presented in units 
per liter serum. 
The ferroxidase level was evaluated using the Erel-spec-
ified method [15]. Although this method is calorimetric 
and automatic, enzymatically, it depends on the oxidation 
of the iron ion. The results were evaluated as the units per 
liter of serum.
 The study protocol was approved by a regional com-
mittee (216).
Statistical analysis
For the comparative between-group analyses (case 
vs control), a chi-squared test was used for the categorical 
variables, and either the Student’s t-test or the Mann-Whit-
ney U test was used for the continuous variables. Inde-
pendent variables were adjusted that reduced the BMI, 
age, parity, gravidity and gestational week effect with the 
independent logistic regression method. Differences were 
considered significant at p < 0.05. All statistical analyses 
explained R-software v.3.5.1 (R statistics software, Institute 
for statistics and mathematics, Vienna, Austria).
RESULTS
Clinical and laboratory results are shown in Table 1. No 
significant differences were found between the groups 
in terms of the maternal age, gestational week, gravid-
ity, parity, fasting glucose level, and BMI. The maternal 
blood CAT levels were significantly higher in the HG group 
(219.6 ± 111.3 kU/L) when compared to the control group 
(71.5 ± 52.5 kU/L) (p < 0.001). The maternal blood MPO levels 
were lower in the control group (121.5 ± 36.3 U/l) than in 
the study group (90.9 ± 56.4 U/L) (p = 0.016). However, the 
ferroxidase levels were similar between the two groups. The 
independent variables BMI, age, parity, gravidity and ges-
tational week effects were adjusted according to the logis-
tic regression method with groups. Significant differences 
were observed between the two groups in the levels of CAT 
(0.001), MPO (0.005) values (Fig. 1–3). 
DISCUSSION
In this study, which lasted less than 14 weeks, an imbal-
ance was found between the serum OS markers and the 
antioxidant defence system markers when 30 pregnant 
women with HG and 30 normal pregnant women were 
compared. Low MPO values and statistically significantly 
higher CAT values were found in the serum samples of the 
HG patients when compared to the controls.
Previous studies have shown that the risks of preeclamp-
sia, placental anomalies, and intrauterine growth retarda-
tion are increased in pregnant women with HG [16], and 
many events are known to cause OS in these women [6]. 
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The construction of reactive oxygen species in the blood is 
known as a normal process, and both enzymatic and non-
enzymatic mechanisms are involved in counteracting the 
OS caused by increased reactive oxygen species levels. CAT, 
MPO, ferroxidase are some of the antioxidants that play this 
critical role [17]. 
HG is characterized by cell-mediated immunity [18]. 
MPO, which is a member of the peroxidase superfamily, is 
found in the azurophilic granules in neutrophils and mono-
cytes. MPO is released by the leukocytes in inflammatory 
conditions, and it catalyzes the formation of various reac-
tive species, including HOCI; therefore, it plays a role in the 
body’s defence against microorganisms [19, 20]. Another 
antioxidant that responds in inflammatory conditions is 
adenosine deaminase (ADA), which is an enzyme necessary 
for the differentiation of lymphoid cells, and it contributes 
Table 1. Comparison between the hyperemesis gravidarum (HG) patients and the healthy controls
Variables 
HG group
Mean ± SD
n = 30
Control group
Mean ± SD 
n = 30
P value P* value
MPO (U/L) 90.9 ± 56.4 121.5 ± 36.3 0.016 0.005
Ferroxidase (U/L) 517.1 ± 99.1 524.7 ± 126.7 0.796 0.917  
Catalase (kU/L) 219.6 ± 111.3 71.5 ± 52.5 < 0.001 0.001  
Maternal age (years) 25.0 ± 2.6 25.6 ± 2.9 0.39
Gestational week 8.52 ± 2.27 7.79 ± 2.02 0.2
Gravidity 2.29 ± 1.37 2.24 ± 1.27 0.88
Parity 1.1 ± 1.16 1.14 ± 1.18 0.89
BMI (kg/m2) 23.1 ± 1.5 23.6 ± 1.1 0.11
Fasting glucose (mg/dL) 87.7 ± 17.9 83.9 ± 9.5 0.31 
SD — standard deviation, BMI — body mass index; MPO — myeloperoxidase 
*The independent variables BMI, age, parity, gravidity and gestational week effects were adjusted according to the logistic regression method with groups
Figure 1. Compared Catalase values for the groups (Boxplot and 
scatter plot relationship between groups)
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Figure 2. Compared Myeloperoxidase values for the groups (Boxplot 
and scatter plot relationship between groups)
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to ferric (Fe3+) form of iron. Ferric form is used for transport 
of iron. Ceruloplasmin (having ferroxidase I), is the predomi-
nant copper protein in plasma having antioxidant activity. 
Abnormalities in ceruloplasmin activity produce cellular iron 
storage that supports ferroxidase activity. The increase in 
copper in iron-deficient anemic mothers could be an offset-
ting mechanism to counteract anemia, and this is comple-
mented by a surge in ceruloplasmin synthesis, which is having 
ferroxidase activity [25, 26]. Onaran et al. [27] found that the 
ceruloplasmin (ferroxidase 1) levels were similar between 
the HG group and the control group. Similarly, we did not 
find a significant difference between the ferroxidase levels 
between the groups. We believe that the levels of ferroxidase 
1 do not change in patients with HG and that the nutrients 
and iron and copper inadequately keep each other in balance.
This study had some limitations. Initially, in the case 
of OS, antioxidant levels other than CAT, MPO and fer-
roxidase should be investigated. Many previous stud-
ies of these antioxidants have revealed different results; 
therefore, more work is needed. In addition, we did not 
analyze the antioxidant status of the patients before their 
pregnancies, which may have affected the OS outcome 
because we could not exclude the possibility of this oc-
curring before the pregnancy. Finally, our sample size 
was small; therefore, future studies should include larger 
sample sizes.
CONCLUSIONS
In this study, the different antioxidant levels in the two 
groups showed that antioxidants, in response to OS, react 
differently with different mechanisms. Also, we believe that 
insufficient food intake suppresses the immune system in 
HG patients, and this plays an important role in the anti-
oxidant levels.
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